Skip to main content
. 2017 Jul;8(7-8):628–639. doi: 10.18632/genesandcancer.148

Figure 3. Co-expression of c-Met with ALDH1A3 or CD133 contributes to poor prognosis in breast cancer patients at tumor stage III-IV.

Figure 3

Kaplan-Meier Survival curves of human breast cancer at tumor stage III-IV. A. c-Met expression. B. ALDH1A1, ALDH1A3, CD44 or CD133 expression. C. c-Met and ALDH1A1, ALDH1A3, CD44 or CD133 expression.